Jump to page content

Search results

  • Press release

    Can the neurological side effects of chemotherapy be prevented?

    Chemotherapy is often associated with severe neurological side effects. The multicenter study PREPARE led by Charité – Universitätsmedizin Berlin now aims to find out whether preventive lithium administration during chemotherapy can alleviate or even entirely prevent neurological complications in breast cancer patients. The SPARK-BIH program of…

  • Press release QUEST Center

    Einstein Foundation Award – The 2022 Awardees

    The €500,000 Einstein Award for Promoting Quality in Research honors researchers and institutions whose work helps to fundamentally advance the quality and robustness of research findings. The recipient of this year’s international Individual Award is Canadian physician Gordon Guyatt for the development of best practices for all areas of clinical…

  • Press release

    Gene Technology Report is now based at the BIH: new brochure and public event on RNA

    The monitoring and interdisciplinary research group Gene Technology Report seeks to promote an objective discourse on genetic technologies in Germany. Renowned natural scientists, social scientists, and humanities scholars present the current state of the art in the field through periodic reports and special topic volumes, taking into account…

  • Media QUEST Center

    Impulspapier: Weiterentwicklung der Indikatorgestützten Mittelallokation für die Forschung in der Hochschulmedizin (ehemals LOM)

    Der Medizinische Fakultätentag (MFT) veröffentlicht Impulspapier: Exzellente Forschung und Lehre erfordern wissenschaftliche Freiräume sowie adäquate strukturelle, finanzielle und räumliche Ressourcen, deren Bereitstellung eine zentrale Managementaufgabe der fakultären Leitungsebene ist. Institutionelle Inzentivierungs- und Belohnungssysteme…

  • Press release

    Why do blood and lymphatic vessels grow unchecked? ERC Starting Grant for René Hägerling

    Anomalies in the formation of blood and lymphatic vessels are, thankfully, rare. Those who do have them face a lifetime of complications that can range from the mild to the life-threatening. To date, little is known about the causes, which means the diagnostic and treatment options are very limited. René Hägerling of the BIH Center for Regenerative…

  • Press release

    What happens when leukemia cells and immune cells meet? ERC Starting Grant for Simon Haas

    Leukemia, a blood cancer, occurs when immature immune cells stop developing but keep dividing and eventually inundate the blood. There, they encounter mature and active immune cells that either recognize and kill the cancer cells or let them escape. Dr. Simon Haas, head of a BIH junior research group within the joint focus area “Single-Cell…

  • Press release

    How genes and small molecules influence our personal disease risk

    Every person has an individual chemical fingerprint. The composition of small molecules in the blood, such as fats or sugars, determines how our body reacts to external influences, which diseases we are susceptible to and how severe an illness will be. In an international collaboration with partners from Cambridge (UK), scientists from the Berlin…

  • Press release

    Three proteins in the blood help to early detect type 2 diabetes risk

    Scientists have used a proteomics approach to identify a three-protein signature in the blood that can improve detection of impaired glucose tolerance, and help identify individuals at high risk of developing type 2 diabetes. The research, led by scientists from the Berlin Institute of Health at Charité (BIH), Germany, and the Medical Research…

Press contact

Dr. Stefanie Seltmann

Head of Communications, Press Spokesperson

Contact information
Phone:+49 30 450 543 019